Trevi Therapeutics
TRVI
#6339
Rank
NZ$1.04 B
Marketcap
$10.85
Share price
1.89%
Change (1 day)
154.51%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2023 (TTM): -$0.51

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.52. In 2022 the company made an earnings per share (EPS) of -$0.94 an increase over its 2021 EPS that were of -$2.52.

EPS history for Trevi Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.51-45.21%
2022-$0.94-62.67%
2021-$2.52-17.29%
2020-$3.0418.17%
2019-$2.57-46.21%
2018-$4.78